Pharmaceuticals
3i makes a 2.3x return on the sale of Xellia
21 May 2013
Royalty Pharma raises offer to $6.4 bn for Irish drugmaker Elan
21 May 2013
The sweetened offer comes just three weeks after Elan sold its interests in multiple sclerosis drug Tysabri to its US partner Biogen Idec
Actavis to acquire Irish specialty drug maker Warner Chilcott for $5 bn
20 May 2013
Warner Chilcott makes a range of products that include well-known oral contraceptives Loestrin 24 FE, Femcon FE and Ovcon
Actavis rejects Mylan’s $15-bn offer
15 May 2013
Mylan’s offer came soon after Actavis put on hold discussions over selling itself to Canada's Valeant Pharmaceuticals International Inc for more than $13 billion
Ranbaxy fined $500 mn by US regulator over drug safety lapses
14 May 2013
Ranbaxy Laboratories Ltd yesterday agreed to pay a record $500 million fine to settle a US civil and criminal lawsuit brought on by a whistle-blower and the US regulator
China continues to push fake drugs and food products into Nigeria
11 May 2013
Nigeria’s top food and drug regulator said in Lagos that China was the source of most fake and substandard medicines and food products imported into the country
Actavis in talks to buy Ireland’s Warner Chilcott
11 May 2013
Actavis, the world's third-largest generic drugmaker today said that it is in “early stage discussions” to buy Irish specialty pharmaceutical company Warner Chilcott Plc
IISc develops novel drug delivery device
08 May 2013
The device, which may cost around Rs9,000, is expected to be in the market in two-and-a-half years, after human trials are completed
AstraZeneca site to emerge as biotech hub
08 May 2013
The BioHub at AstraZeneca's site provides 36,000 sq ft of high-end laboratory and office facilities for early-stage and growing firms engaged in innovative drug discovery and development
Johnson & Johnson recalls children’s Tylenol in South Korea
06 May 2013
The South Korean regulator says that the recall was issued after the company delayed the recall by a month and flouted quality-control regulations
Johnson & Johnson’s plant licence revoked on quality concerns
04 May 2013
According to the FDA, the J&J plant at Mulund, near Mumbai, has been using ethylene oxide, a harmful chemical, in place of steam to sterilize baby power
Valeant Pharma's $13-bn Actavis deal put on hold
29 Apr 2013
One of the biggest health care deals of the year has been put on hold with Valeant Pharmaceuticals and Actavis disgreeing on the size of the cash premium to be paid
After kickbacks to pharmacies, Novartis now sued for bribing US docs
27 Apr 2013
The new lawsuit this week comes just a few days after the US government slapped a civil health care fraud lawsuit against the Basel-based company for allegedly paying kickbacks to at least 20 pharmacies
Russia blocks Abbott Laboratories - Petrovax merger
20 Apr 2013
The deal would have made Abbott the first overseas pharmaceutical company to own vaccine manufacturing facilities in Russia.
Featured articles
Lighter than air, yet very, very powerful
By Kiron Kasbekar | 03 Jan 2024
In March 2013 Chinese scientists pulled off a remarkable feat. They created the world’s lightest aerogel. Tipping the scales at a mere 0.16 milligrams per cubic centimeter – that’s a sixth of the weight of air!
COP28 explained: A closer look at COP28's climate change solutions
By Aniket Gupta | 27 Dec 2023
The 28th United Nations Climate Change Conference, also known as COP28, took place from 30th November 2023, to 13th December 2023, at Expo City in Dubai, United Arab Emirates.
What is a Ponzi scheme?
By Aniket Gupta | 06 Dec 2023
Ponzi schemes have long captivated the public imagination, drawing unsuspecting investors into a web of illusion and deception.
The Rise and Rise of HDFC Bank
03 Jul 2023
HDFC, which surged ahead of global majors like HSBC Holdings Plc and Citigroup Inc and left Indian peers like State Bank of India and ICICI Bank in market capitalisation, now ranks fourth largest among the world’s most valuable banks, after JPMorgan Chase & Co, Industrial and Commercial Bank of China Ltd and Bank of America Corp
India’s Millet Revolution To Enrich Global Food Basket
02 Apr 2023
Millets, a healthier and cheaper substitute to wheat and rice, are indigenous to many parts of the world, especially in the semiarid tropics of Asia and Africa, and offers a big scope for expanding production and consumption in the foodgrain deficient African continent
Market predator Hindenburg preys on Adani stock
06 Mar 2023
Almost a month after the damning report of short-seller Hindenburg Research on the Adani Group that claimed that the seven stocks within the group were about 85 per cent overvalued, one of the group's stocks, Adani Total Gas, closed at Rs835 on the BSE, down nearly 79 per cent from its 24 January level, almost close to reaching that valuation
.jpg "CBDT explains Budget proposal on capital gains tax")
.jpg "Economic Survey projects India’s GDP growth at 6.5–7% in 2024-25")
.jpg "Adani-Sirus joint venture to acquire 77.5% stake in Coredge.io parent Parserlabs")
